Literature DB >> 22524811

Long-term prognosis in hepatocellular carcinoma patients after hepatectomy.

Lei Zhou1, Chang Liu, Fan-Di Meng, Kai Qu, Feng Tian, Ming-Hui Tai, Ji-Chao Wei, Rui-Tao Wang.   

Abstract

BACKGROUND: The hepatocellular carcinoma is very common in China. Our aim in this report was to investigate clinical and pathological factors based on the current decade data that could influence prognosis of HCC patients after hepatectomy.
METHODS: Between 2002 and 2009, all patients undergoing hepatectomy for HCC were followed up and reviewed retrospectively. Prognostic factors were studied by univariate and multivariate analysis, with Kaplan-Meier and Cox multivariate survival analyses.
RESULTS: Complete clinicopathologic and follow-up data were available for 114 patients. The estimated cumulative survival rates at 1, 3, and 5 yr were 84.6%, 60.2% and 51.8%, respectively. On univariate analysis, key prognostic factors were AFP level, GGT level, tumor size, number of tumors, portal vein invasion, liver cirrhosis status and TNM stage. In the multivariate analysis, tumor size, GGT level, liver cirrhosis status and portal vein invasion were significantly associated with patients' prognosis.
CONCLUSION: Through follow-up of a relatively large cohort of Chinese patients, tumor size, GGT level, liver cirrhosis status, portal vein invasion were revealed as important factors for long-term survival after hepatectomy. Early diagnosis for tumor and the improvement of liver function before surgery are important ways to improve the prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 22524811     DOI: 10.7314/apjcp.2012.13.2.483

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Bioinformatics analysis reveals potential candidate drugs for HCC.

Authors:  Xiao-Bing Huang; Jing Li; Lu Zheng; Guo-Hua Zuo; Ke-Qiang Han; Hong-Yan Li; Ping Liang
Journal:  Pathol Oncol Res       Date:  2013-01-23       Impact factor: 3.201

2.  Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.

Authors:  Dan-Hong Yang; Wei-Ping Wang; Qiang Zhang; Hong-Ying Pan; Yi-Cheng Huang; Jia-Jie Zhang
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

3.  Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.

Authors:  Xin Wang; Zusen Wang; Liqun Wu
Journal:  BMC Surg       Date:  2016-04-19       Impact factor: 2.102

4.  The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review.

Authors:  Yang Ou; Junwei Huang; Liping Yang
Journal:  Biosci Rep       Date:  2018-11-28       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.